InvestorsHub Logo
Followers 658
Posts 19670
Boards Moderated 6
Alias Born 07/03/2011

Re: None

Thursday, 01/04/2024 7:21:06 AM

Thursday, January 04, 2024 7:21:06 AM

Post# of 73
Omega Therapeutics Stock Surges 99% Following Pact with Novo Nordisk to Treat obesity
Published: Jan. 4, 2024 at 7:06 a.m. ET
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
January 04, 2024 05:59 ET
| Source: Novo Nordisk A/S
Share






Omega collaboration will leverage the company’s platform to develop an epigenomic controller as part of a new approach to obesity management
Cellarity collaboration will build upon initial work and engage the company’s platform to develop a small molecule therapy in metabolic dysfunction-associated steatohepatitis (MASH)
First two research programmes signed under existing partnership between Novo Nordisk and Flagship Pioneering
Novo Nordisk will reimburse R&D costs and each company and Flagship’s Pioneering Medicines are eligible to receive up to 532 million US dollars in upfront and milestone payments, as well as tiered royalties
Bagsværd, Denmark, Cambridge, Mass., and Somerville, Mass. 4 January, 2024 – Novo Nordisk, Omega Therapeutics, Inc.
https://www.globenewswire.com/news-release/2024/01/04/2803788/0/en/Novo-Nordisk-enters-into-research-collaborations-with-Omega-Therapeutics-and-Cellarity-on-novel-treatment-approaches-for-cardiometabolic-diseases.html
0.5012
-0.0478 (-8.71%)
Volume: 502,057
Day Range: 0.503 - 0.551
Bid: 0.5005
Ask: 0.5087
Last Trade Time: 5:36:55 PM EST
Total Trades: 1,309
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OMGA News